SIRT1 and COVID-19: In addition, the activation of SIRT1/3 notably improves mitochondrial function [135], implying their evident role in the context of hypoxic and oxidative stress, mitochondrial dysfunction, and related apoptosis, inflammation, and immune function, being a putative pathway identified in the progression of COVID-19, with mitochondria being noted as relevant targets for treatment [96, 134].